Bitcoin is once again moving closely in step with US stocks, at just about the worst time for crypto diehards. As equities come under renewed pressure following days of volatility tied to the conflict ...

The tech sell-off continued on Wall Street as the tech-heavy Nasdaq Composite and the S&P 500 benchmark sank on Feb. 4. While the former was down 1.8%, the latter was down 0.6% at press time. Nearly ...

Bitcoin is increasingly behaving like a software stock, with its latest correction unfolding alongside the broader software sell-off. The relationship between bitcoin and software equities has ...

Abstract: Relation prediction in knowledge graphs is critical for uncovering missing links between entities. Previous models mostly focused on learning the distance of entities and relation within ...

The pandemic-era interactive workout mirror is getting a beauty equivalent. Called Swan Beauty, the new AI and AR mirror that features skin analysis, product recommendations, routine tracking, creator ...

ABSTRACT: Pyrethrum (Chrysanthemum cinerariaefolium L.) is an industrial crop with complex morphology and diverse physico-mechanical properties that jeopardize the optimal design of precision ...

What causes low yield in wafers? Usually it’s due to design or process changes, but sometimes yield issues occur even if there haven’t been any changes from one manufacturing lot to the next. Finding ...

The semiconductor industry is entering an era defined by heterogeneous integration and complex packaging technologies. Innovations such as wafer-on-wafer bonding, chiplets, multi-stacked die (2.5D/3D) ...

Did you know you can customize Google to filter out garbage? Take these steps for better search results, including adding my work at Lifehacker as a preferred source. I usually focus on something a ...

Physics and Python stuff. Most of the videos here are either adapted from class lectures or solving physics problems. I really like to use numerical calculations without all the fancy programming ...

Phase II study of trastuzumab-pkrb plus gedatolisib in patients with HER2-positive metastatic breast cancer who progressed after 2 or more HER2-directed chemotherapies (KM-10A/KCSG BR18-13). This is ...